IMGN Financial Facts

Research and development: 38.2M
Net loss: -33.23M
See Full Income Statement

Accrued compensation: 5.46M
Total current assets: 223.25M
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 4/25/16 *Est. EPS Growth Rate -337.5% *Last Qtr.
Average EPS % Beat Rate -31.0% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -7.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/29/16 Q216 -$0.38-$0.36 -$0.02N/A$17.87M N/A Details
10/27/15 Q116 -$0.39-$0.35 -$0.04$14.9M$15.84M N/A Details
7/31/15 Q415 -$0.71-$0.35 -$0.36$12.61M$15.42M N/A Details
4/24/15 Q315 -$0.25-$0.24 -$0.01$11.4M$20.95M N/A Details
1/30/15 Q215 $0.16-$0.05 +$0.21$48.3M$37.3M N/A Details
10/24/14 Q115 -$0.26-$0.15 -$0.11$13.2M$21.8M N/A Details
8/1/14 Q414 -$0.83-$0.32 -$0.51$5.74M$9.72M N/A Details
4/25/14 Q314 -$0.44-$0.27 -$0.17$6.9M$13.28M = Details